A new genetic clue for early-onset Alzheimer’s disease
A genome-wide study of families with early-onset Alzheimer’s disease has identified the RNA-binding protein gene RBFOX1 as a significant genetic locus linked to the age at which symptoms begin. The research, which combined linkage analysis with validation across multiple independent cohorts, found that higher expression of RBFOX1 in blood was associated with an earlier disease onset. This suggests that RBFOX1 may influence the timing of dementia, nominating it as a potential therapeutic target for delaying or preventing Alzheimer’s disease.
Why it might matter to you:
This work demonstrates a powerful approach for uncovering genetic modifiers of disease onset, a strategy directly applicable to research on neurodevelopmental disorders. Identifying genes like RBFOX1 that influence the timing of neurological disease could provide new mechanistic insights and potential intervention points for conditions where age of onset is a critical variable.
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.